Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lifecore Biomedical (LFCR) Change in Acquisitions & Divestments: 2009-2019

Historic Change in Acquisitions & Divestments for Lifecore Biomedical (LFCR) over the last 5 years, with Nov 2019 value amounting to $68,000.

  • Lifecore Biomedical's Change in Acquisitions & Divestments fell 65.13% to $68,000 in Q4 2019 from the same period last year, while for Nov 2019 it was $714,000, marking a year-over-year decrease of 87.68%. This contributed to the annual value of $364,000 for FY2020, which is 33.21% down from last year.
  • Latest data reveals that Lifecore Biomedical reported Change in Acquisitions & Divestments of $68,000 as of Q4 2019, which was down 77.03% from $296,000 recorded in Q3 2019.
  • In the past 5 years, Lifecore Biomedical's Change in Acquisitions & Divestments registered a high of $4.4 million during Q1 2015, and its lowest value of $68,000 during Q4 2019.
  • Moreover, its 2-year median value for Change in Acquisitions & Divestments was $195,000 (2018), whereas its average is $181,800.
  • Data for Lifecore Biomedical's Change in Acquisitions & Divestments shows a maximum YoY plummeted of 94.66% (in 2016) over the last 5 years.
  • Lifecore Biomedical's Change in Acquisitions & Divestments (Quarterly) stood at $1.0 million in 2015, then tumbled by 94.66% to $233,000 in 2016, then reached $195,000 in 2018, then slumped by 65.13% to $68,000 in 2019.
  • Its Change in Acquisitions & Divestments was $68,000 in Q4 2019, compared to $296,000 in Q3 2019 and $141,000 in Q2 2019.